The 18th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place this earlier this week in New York City at the Waldorf Astoria with more than 1,400 registrants, including over 600 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 6 fireside chats with biopharma CEOs as well as a special guest, New York Senator Chuck Schumer. The event also hosted 190 company presentations and record breaking 2,580 One-on-One Partnering™ meetings, shattering last year’s all-time record.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsSustainability BIOTECH health biotech industry Greenhouse Gas Emission agriculture BIO CEO & Investor Conference global food crisis Patent Reform Plant biotechnology GMOs Benefits of biotech crops BIO Investor Forum International vaccines healthcare BIO EVENT climate change Food biotechnology
- Most Popular